A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers

Autor: Sharma, Hitt, Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Kawade, Anand, Lalwani, Sanjay, Ravi, M.D., Ramanan, Padmasani Venkat, Kamath, Veena, Agarwal, Anurag, Dogar, Vikas, Gautam, Manish, Jaganathan, K.S., Kumar, Rakesh, Sharma, Inderjit, Gairola, Sunil
Zdroj: In Vaccine 2 December 2024 42(26)
Databáze: ScienceDirect
Externí odkaz: